Screenin3D is a company that develops microfluidic technology for cancer therapy assessment, enabling the testing of CAR-T cells and combination therapy on miniaturized solid cancer models.

Precision medicine and drug development based on maximising screening of limited human cancerous tissue in 3D with microfluidic technology.

ScreenIn3D

ScreenIn3D is getting ready to attend the Next Gen Organ-on-Chip & Organoids workshop organized by CSEM in Zurich on August 24-25th!

A fantastic venue to meet #clinicians, #scientists, #researchers and decision makers from the #pharma & #biotech industry and share the latest breakthroughs in #OrganOnChip.
 
We are delighted to contribute to the exciting scientific program with a talk from our CEO, Michele Zagnoni, who will be showcasing our tumour-on-a-chip platform for precision oncology. We hope to see you there at 4:50pm on day 1.
 
#OrganOnChip #Organoids #CSEM #Research #TumourOnAChip

COM:SCREENIN3D

Screenin3D

Analysis Not Available